Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move
(TSXV: $FAF.V) (TSXV: $OGI.V) (NASDAQ: $OGI) (TSX: $TGOD.TO) (TSX: $WEED.TO)
(NYSE: $CGC)
Delta, Kelowna, BC –June 20,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/06201FAF-OGI-TGOD-WEED-CGC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
Today we are looking at a few early announcements.
The
Canadian Cancer Society (CCS) is calling for immediate government action to address a significant and troubling
increase in youth vaping in Canada. The increase in rates was revealed in a new
study published in the British Medical Journal.
The
study, led by Professor David Hammond of the University of Waterloo, found that
among those 16-19 years old, vaping increased by a stunning 74% from 2017 to
2018, from 8.4% to 14.6%. The study was conducted in August/September 2017 and
again in August/September 2018.
The
study presents the first data since the major tobacco companies launched and
heavily advertised their own e-cigarette brands in Canada following the May
2018 adoption of Bill S-5 which legalized e-cigarettes with nicotine. The study
results are consistent with indications from across Canada of high schools
struggling to respond to a rapid increase in youth vaping.
Evidence
indicates that youth who use e-cigarettes with nicotine may become addicted and
are at increased risk of becoming smokers.
The
study also found that cigarette smoking among 16-19 year-olds in the same 2017
to 2018 time period increased by 45%, from 10.7% to 15.5%. Prior surveys up to
and including 2017 had shown a continuing decline in youth smoking. However,
these concerning results indicate that youth smoking may now be increasing.
"E-cigarettes
are supposed to be for adult smokers who have been unable to quit," says
Rob Cunningham, Senior Policy Analyst, CCS. "But the results of this new
study regarding youth trends are of tremendous concern. Given the progress that
has been made to reduce youth smoking, we must avoid a new generation of
teenagers becoming addicted to nicotine through vaping products."
CCS
urges provinces to increase the minimum age to 21 for the sale of both tobacco
and vaping products, as 16 US states have already done. Provinces should also
prohibit the sale of flavoured vaping products except in adult-only specialty
vape shops. Alberta and Saskatchewan, the only provinces without legislation on
vaping products, should immediately adopt comprehensive legislation. Ontario
should ban vaping product advertising in convenience stores and other
retailers, as seven other provinces have done.
CCS
recommends that the federal government move quickly to adopt regulations
restricting the advertising of vaping products, ensuring regulations are at
least as restrictive as advertising for cannabis, including medical cannabis.
The federal government should also adopt restrictions on the use of flavours in
vaping products, along with other regulatory measures.
Fire & Flower Holdings Corp. and
its wholly-owned subsidiary Fire & Flower Inc. (TSXV:
FAF), today
announced that it has received an additional
licence from the Alberta Gaming, Liquor and Cannabis Commission (the
"AGLC") to open its second licensed cannabis retail store in Calgary,
Alberta.
The store will be located at 7108 MacLeod
Trail, Calgary, Alberta and is the 19th Fire & Flower branded,
licenced store location in the Company's retail network. This announcement
follows Fire & Flower's previous news release on May 31, 2019 announcing
the Company' near-term store rollout schedule.
"Our team is excited to open a
second licensed cannabis retail store in the major market of Calgary and we
look forward to welcoming Calgarians into our new location," shared Trevor
Fencott, Fire & Flower's Chief Executive Officer. "Fire & Flower
had built out this location in anticipation of the issuance of additional
cannabis retail licences in the province of Alberta. Receiving our licence to
operate this store validates our strategy of building locations in advance and
creates a clear path to rapidly opening new markets."
It is anticipated that the second Calgary
licensed store will open the week of July 8. The location has been open since
January 2019 to showcase the Fire & Flower retail experience including
best-in-class cannabis education. Once cannabis products have been received,
the location will offer a full assortment of cannabis products from licensed
producers.
Organigram Holdings Inc. (TSXV:
OGI) (NASDAQ:
OGI), the parent company of Organigram Inc.,
announced that
it has now shipped its first cannabis products to the province of Quebec,
following purchase orders placed with the Société québécoise du cannabis (SQDC)
and following registration with the Autorité des Marchés Publics.
A true national player in Canada's legal
adult use recreational cannabis marketplace, the Company has now distributed
products for sale to all ten Canadian provinces.
"We are pleased to now officially
ship our products coast to coast," says Greg Engel, CEO, Organigram.
"Our national reach means brands such as Edison Cannabis Co. and
Trailblazer are available across the country, offering a range of cannabis
options for legal adult recreational cannabis consumers."
Organigram's currently available product
portfolio includes value, mainstream and premium product offerings across the
categories of dried flower, pre-rolls, and oils.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) announced its
expansion into the global organic hemp CBD market with the launch of its Global
Strategic Hemp Division. This new division will leverage TGOD's solid expertise
in the European hemp CBD market to fuel growth and accelerate the development
and commercialization of new products across its network of international
partners.
"With the global CBD market expected
to hit $22 billion in less than 3 years, it is clear that the segment is
drawing substantial consumer demand," commented Brian Athaide, CEO of
TGOD. "Our team has years of direct
hands-on experience in the CBD space and we are excited to use this advantage
to execute on a fast-moving market expansion strategy. CBD is a wellness product and has a natural
fit with TGOD's certified organic positioning and the large segment of
consumers who are increasingly demanding natural and organic products. The time to act is now, and TGOD has the
team, the infrastructure and the capital to establish a significant presence in
this market."
TGOD's acquisition of HemPoland in 2018
will continue to provide the Company with significant intellectual property and
valuable insights as its Global Strategic Hemp Division expands into emerging
hemp CBD markets. HemPoland saw its revenue for the first quarter grow by
nearly 30% quarter over quarter as demand for high-quality hemp CBD products in
Europe gains momentum.
Canopy Growth Corporation (TSX:
WEED) (NYSE:
CGC) announced that,
at a special meeting of the Company's shareholders held earlier today, the
Company's shareholders voted overwhelmingly in favour of the resolution
approving the issuance of common shares of Canopy Growth and certain amendments
to certain outstanding Company warrants in connection with the Company's
previously announced proposed acquisition of Acreage Holdings, Inc..
The Canopy Shareholder Resolution was
approved by approximately 99.05% of
votes cast by disinterested Canopy Growth shareholders either in person or
represented by proxy at the Meeting, in accordance with the requirements of the
Toronto Stock Exchange. The report of voting results will be made available
under Canopy Growth's profile on SEDAR at www.sedar.com.
In addition to the approval by Canopy
Growth shareholders, Acreage shareholders approved the Transaction at a special
meeting of shareholders held simultaneously today.
"On behalf of Canopy Growth, I thank
the shareholders of both companies for their vote of confidence in this
historic transaction," said Bruce Linton, Chairman & Co-CEO, Canopy
Growth. "Completion of the Transaction is intended to position us to
efficiently and effectively enter the US cannabis market once federally
permissible. Alongside our international market strategies and US Hemp
strategy, we believe the acquisition of Acreage will be a key step in
bolstering our position as a truly global company."
Initial implementation of the Transaction
is subject to approval by the Supreme Court of British Columbia and
satisfaction of certain other closing conditions. Canopy Growth and Acreage
expect the Transaction to be implemented on or about June 27, 2019. Completion
of the Transaction is contingent on the occurrence or waiver, at Canopy
Growth's discretion, of changes in US federal law to permit the general
cultivation, distribution, and possession of cannabis or to remove the
regulation of such activities from the federal Laws of the United States.
Details of the payment will be included in a subsequent press release.
Boozer Inc. introduced Super Anytime Inc. , a wholly owned
subsidiary of Boozer, and to announce Super has signed a Letter of Intent for a
strategic partnership with Pineapple Express Delivery Inc. ("PED").
The Partnership will enable same-day, direct-to-consumer delivery of remote
orders of recreational cannabis products from licensed retailers across Canada1
by leveraging Boozer's expertise in front-end consumer acquisition and
mobile-app marketplaces, with PED's proven best-in-class last-mile delivery
services. Canadians will soon be able to shop from multiple retailers via
Super's unified e-commerce platform, with PED enabling integrated fulfillment
and same-day delivery services.
Founded
in 2017, Boozer is Canada's first mobile-app marketplace for compliant,
on-demand, ordering of alcohol. Since inception, Boozer has developed a proven
track record for accountability, compliance, and superior logistics, in a
highly regulated industry with highly regulated products. Currently active in
Toronto and Vancouver, Boozer seeks to consolidate the Canadian
business-to-consumer alcohol market. Through Super, the Company is replicating
its existing technology platform and capabilities to enter the emerging
recreational cannabis market. Launching this year, Super seeks to make legal
cannabis delivery a preferred option among consumers by presenting a
convenient, safe, and enjoyable order and delivery experience, all in a manner
that is compliant with provincial regulations.
PED
is a leading Canadian cannabis delivery service and has been providing same-day
delivery options to the legal Canadian cannabis market since October 2018.
Boasting over 10 years experience providing on-demand last-mile delivery in
various product categories, PED currently has a presence in many of Canada's largest
markets, including Ontario, Manitoba, and Saskatchewan (Regina and Saskatoon),
for both adult-use and medical deliveries (provincial regulations permitting).
"We're
very excited to partner with the Super team and technology platform," said
Randy Rolph, CEO of Pineapple Express Delivery. "Having observed the
Boozer platform from afar, we were excited for the opportunity to partner with
a group that has already achieved great success in generating orders of legal,
government controlled substances that require compliant last-mile fulfillment
services," he added.
Syqe Medical, a leading pharma-tech company, today announced the launch of the world's first
pharmaceutical-grade metered-dose cannabis inhaler in Israel, empowering
physicians to prescribe precise dosages meeting pharmaceutical standards. The
debut of this drug delivery device reflects Syqe's mission to transform medical
cannabis into a mainstream medical treatment.
This
benchmark news is the culmination of eight years of research and development –
including rigorous testing through multiple clinical trials – including four
years of paving a novel regulatory path. The Syqe Inhaler and supporting
clinical research is poised to unlock the global medical cannabis market by
eliminating uncertainty surrounding dosage administration and alleviating
physician concerns with regards to adverse events and psychoactivity. In turn,
this will enable greater physician adoption of medical cannabis. Syqe's
breakthrough drug delivery technology introduces complex respiration technique
automation, electronic selective dosing and remote clinical monitoring and dose
control, significantly expanding the applicability of this platform well beyond
cannabis.
"80%
of cannabis patients inhale the plant. For too long, physicians who wish to
treat these patients have been without the most basic clinical knowledge on
dosing, efficacy and adverse events of cannabis," says Perry Davidson, CEO
and Founder of Syqe Medical. "For eight years Syqe has been developing
proprietary technologies for the administration of raw plants, and through our
clinical trials we were able to determine the recommended dosage of inhaled
cannabis down to the microgram. This launch marks the beginning of a new
chapter in pain treatment, one in which physicians can confidently prescribe
precise dosages of cannabis, and patients can reap the rewards, effectively and
responsibly."
The
Syqe Inhaler, a non-combustion drug delivery device, has received the world's
first ever regulatory approval from the Israeli Ministry of Health as a medical
device combined with cannabis, and will be available for purchase by licensed
patients in Israel.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
